SGD’s new pharma division has Alain Comel as its CFO, who will be responsible for setting up the financial department, and will be part of the Executive Committee, also supporting growth strategy.
SGD has announced Alain Comel’s appointment as Chief Financial Officer for the future pharmaceutical division. Responsible for setting up the financial department of the new pharmaceutical entity, Alain Comel will be part of the Executive Committee and will support the growth’s strategy of the new entity.
Alain Comel has been CFO for the past 25 years, out of which more than half spent abroad (Netherlands, UK, Spain, Indonesia and Switzerland). Before joining SGD, Alain was CFO of MeadWestvaco, NY listed company providing packaging solutions to the healthcare, beauty and personal care industries worldwide.
Alain Comel brings significant expertise in the finance, IT and business development departments where he worked in many industries such as the automotive or the medical devices and special nutrition ones. He holds a Master in Management and a degree in restructuring from the Metz Business School and the law faculty.
French SGD Group is the global leader in glass packaging for perfumery, cosmetics and pharmacy. The group, who conducts its business operations through an approach based on quality, innovation and sustainability, produces more than 3 billion flasks each year. SGD has developed more than a century of glass know-know in France and now operates 11 production sites and 10 commercial hubs throughout France, Germany, Spain, Italy, Brazil, China and the US. The group has more than 4,500 employees around the world with around 2,000 in France. SGD generated revenue of EUR 574 million in 2014.
In 2014, the group started a process of separating its perfumery and pharmaceutical businesses in order to create two global leaders in each activity.